Search

everythinglearnresearchcommunity

for

Search:↓

The combination treatment showed a higher response rate but no significant survival benefits.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

The combination of encorafenib and binimetinib caused few skin issues.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

Cancer treatments often cause skin, nail, and hair problems.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Rapamycin treatment helps reduce brain inflammation and symptoms of mitochondrial disease by blocking specific pathways in mice.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

Blocking mTORC1 reduces skin tumor growth in mice.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.